An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing

This bill expands the Maine Prescription Drug Affordability Board from five to six members, adding the executive director of the Maine Health Data Organization as a non-voting member. It directs the board to assess strategies to lower prescription drug costs for both public and private health plans, including implementing reference-based pricing and establishing upper payment limits. The board will also develop a program to reduce the impact of prescription drug costs on the state's healthcare system and submit a preliminary plan by January 30, 2026.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text

• ME LD105An Act to Implement the Recommendations of the Commission Regarding Foreign-trained Physicians Living in Maine to Establish a Sponsorship Program for Internationally Trained Physicians
• ME LD107An Act to Require Health Insurance Coverage for Biomarker Testing
• ME LD169Resolve, Establishing the Commission to Study MaineCare Estate Recovery
• ME LD331Resolve, Directing the Department of Health and Human Services to Ensure Timely Reimbursement Under MaineCare Regarding Hospital Cost Reports
• ME LD335An Act to Safeguard Reproductive Rights